Diametric Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Diametric Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,967	Closed	-$332K	–	159
2019 Q1	$332K	Sell	1,967 -4,427	-69%	-$659K	0.26%	80
2018 Q4	$623K	Buy	6,394 +584	+10%	+$76.6K	0.48%	69
2018 Q3	$1M	Buy	+5,810	New	+$838K	0.87%	47
2018 Q1	–	Sell	-6,102	Closed	-$806K	–	132
2017 Q4	$806K	Buy	+6,102	New	+$717K	0.49%	74

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Diametric Capital's GWPH Position: Q2 2019 in Review

Diametric Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 1,967 shares — an estimated $332K sold.

Diametric Capital first reported a position in GWPH in Q4 2017 and held it in 4 quarters. The position peaked at $1M in Q3 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

Diametric Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Diametric Capital sold 1,967 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $332K.
Diametric Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 4 quarters.
Diametric Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1M in Q3 2018.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Diametric Capital's 13F filing for Q2 2019, filed 14 Aug 2019.